Vitamin K2 has been called "the forgotten vitamin" — it's distinct from the more well-known vitamin K1, works through different mechanisms in the body, and has an emerging evidence base suggesting important roles in bone health, cardiovascular health, and possibly dental and cognitive health. Despite these findings, many healthcare providers and patients conflate K1 and K2 as if they're interchangeable. They're not — and understanding the difference may genuinely matter for your health.
Vitamin K1 vs. K2: Fundamentally Different Roles
Vitamin K1 (phylloquinone) is found predominantly in dark leafy greens — spinach, kale, broccoli, Brussels sprouts. It's primarily involved in blood clotting — activating clotting factors in the liver. This is the form most people encounter when told to maintain consistent "vitamin K" intake on blood thinners like warfarin.
Vitamin K2 (menaquinone) is found in fermented foods and animal products. Unlike K1, it circulates in the body for much longer and reaches tissues beyond the liver — particularly bone, arterial walls, and other soft tissues. Its primary role involves activating K2-dependent proteins that regulate calcium metabolism throughout the body, directing calcium into bones and teeth while potentially helping prevent it from accumulating in arterial walls and soft tissues where it doesn't belong.
The Forms of Vitamin K2
Vitamin K2 itself comes in multiple forms called menaquinones (MK), numbered by the length of their side chain:
- MK-4: Found in animal products (butter, egg yolks, chicken breast, certain cheeses). Short chain length means rapid absorption but also faster clearance — half-life of about 1 hour
- MK-7: Found primarily in natto (fermented soybeans — the richest dietary source of K2) and some other fermented foods. Longer chain length produces a much longer half-life — approximately 3 days — meaning it circulates longer and reaches more tissues with a single daily dose. Most supplement research uses MK-7
- MK-9, MK-10: Found in some fermented cheeses — less studied
How Vitamin K2 Works: The Calcium Connection
The key mechanism involves two K2-dependent proteins:
- Osteocalcin: A protein produced by bone-building osteoblasts that, when activated by K2 (via carboxylation), binds calcium and incorporates it into bone matrix. Undercarboxylated osteocalcin (indicating K2 insufficiency) is associated with lower bone density and higher fracture risk
- Matrix Gla Protein (MGP): A protein found in arterial walls and soft tissues that, when activated by K2, inhibits arterial calcification — the buildup of calcium deposits in artery walls that contributes to cardiovascular disease. Unactivated MGP is a marker of vascular calcification risk
This dual role — supporting calcium's deposition in bones while potentially inhibiting its deposition in arteries — is what makes K2 theoretically attractive for both bone and cardiovascular health.
Evidence for Health Benefits
Bone Health
Several RCTs and large population studies support K2's role in bone health:
- A large Japanese clinical trial (the MK-4 meta-analysis) found pharmacological doses of MK-4 (45mg daily — much higher than food-level intake) reduced fracture risk by 60–80% in osteoporotic Japanese women, leading to MK-4 (Menatetrenone) being approved as a drug for osteoporosis treatment in Japan
- A 2019 randomized trial in the New England Journal of Medicine found MK-7 supplementation (180mcg daily for 3 years) improved bone strength in healthy postmenopausal women
- Population studies consistently show associations between higher dietary K2 intake and better bone density and lower fracture risk
Cardiovascular Health
The Rotterdam Study — a large Dutch cohort following over 4,800 participants — found that the highest dietary K2 intake was associated with a 57% lower risk of cardiovascular death and significantly less aortic calcification compared to the lowest intake. Crucially, dietary K1 showed no such association — suggesting this is specifically a K2 effect. MGP, activated by K2, is the key protein proposed to inhibit vascular calcification in this context.
Randomized trials with K2 supplementation show reductions in arterial stiffness in specific populations (kidney disease, healthy postmenopausal women), and reductions in dp-ucMGP (a marker of MGP inactivation and thus K2 insufficiency) with supplementation.
Dental Health
Vitamin K2 activates a protein called osteocalcin in the teeth (analogous to its bone role), which some research and Weston Price's historical anthropological work suggests may be involved in dental health and resistance to decay. This area has less rigorous RCT evidence than bone and cardiovascular effects but remains an active research interest.
Best Food Sources of K2
| Food | K2 Content | Primary Form |
|---|---|---|
| Natto (fermented soybeans) | ~900–1000 mcg/100g | MK-7 (by far the richest source) |
| Gouda cheese | ~75 mcg/100g | MK-8, MK-9 |
| Brie/Edam cheese | ~50–60 mcg/100g | MK-8, MK-9 |
| Egg yolk | ~15–30 mcg/100g | MK-4 |
| Chicken breast/leg (dark meat higher) | ~10–35 mcg/100g | MK-4 |
| Butter (grass-fed higher) | ~10–15 mcg/100g | MK-4 |
| Beef liver | ~11 mcg/100g | MK-4 |
Natto's K2 content is extraordinary — a single 100g serving provides roughly the entire amount shown to benefit bone health in supplementation studies. It's an acquired taste that many Westerners find challenging, but it's the most nutritionally dense K2 food by a significant margin.
Supplementation
Typical supplemental doses of K2 range from 100–200 mcg of MK-7 daily — this is the form and dose range most studied in recent bone and cardiovascular RCTs. MK-7 is preferred over MK-4 in supplements because its long half-life means once-daily dosing maintains stable circulating levels, whereas MK-4's rapid clearance requires much higher doses (pharmacological 45mg in Japanese studies, not achievable with standard supplements) to see similar effects.
K2 supplements are fat-soluble — take with a meal containing dietary fat for optimal absorption. K2 is often combined with vitamin D3 in supplements since both are important for calcium metabolism and may work synergistically — vitamin D promotes calcium absorption while K2 influences where calcium goes once absorbed.
Safety and Drug Interactions
Vitamin K2 at typical supplemental doses (100–200 mcg MK-7) is considered safe for most people. The main drug interaction concern is with warfarin (coumadin) — vitamin K (including K2) antagonizes warfarin's blood-thinning action. People on warfarin should not change their vitamin K intake significantly without medical supervision and INR monitoring. Newer oral anticoagulants (apixaban, rivaroxaban, dabigatran) are not vitamin K-dependent and don't interact with dietary K2 in the same way — though always confirm with your prescribing physician.
Frequently Asked Questions
1. Geleijnse JM et al. "Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease." Journal of Nutrition. 2004 (Rotterdam Study). academic.oup.com/jn
2. Knapen MHJ et al. "Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women." Osteoporosis International. 2013.
3. Maresz K. "Proper Calcium Use: Vitamin K2 as a Promoter of Bone and Cardiovascular Health." Integrative Medicine. 2015.
4. NIH Office of Dietary Supplements. "Vitamin K Fact Sheet." 2024. ods.od.nih.gov
